Your session is about to expire
← Back to Search
Dietary Supplement
BIG MACS Diet for Colon Cancer
Phase < 1
Waitlist Available
Led By Cyrus Jahansouz
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Primary diagnosis of colon cancer, stages 1-3
Age 25-70 years
Must not have
Previous organ transplantation
Self-reported HIV-positive status, active tuberculosis, active malaria, chronic hepatitis B or C, cirrhosis, or inflammatory bowel disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, time of surgery, postop day 7 and 30
Awards & highlights
No Placebo-Only Group
Summary
This trial will test a special diet to help colorectal cancer surgery patients. The diet aims to improve outcomes by providing beneficial bacteria with more carbohydrates.
Who is the study for?
This trial is for English-speaking adults aged 25-70 with a primary diagnosis of colon cancer stages 1-3, who can consent and follow the study protocol. Excluded are those with significant health issues like anemia or liver problems, BMI <20 or >40, psychiatric conditions affecting adherence, history of substance dependency within five years, certain surgeries or diseases (like IBD), and pregnant/nursing individuals.
What is being tested?
The BIG MACS Diet aims to optimize gut microbiome before colorectal surgery by providing more microbiota accessible carbohydrates compared to a standard diet. The goal is to see if this special diet improves patient outcomes after surgery.
What are the potential side effects?
Since this trial involves dietary changes rather than medication, side effects may include gastrointestinal discomfort such as bloating or changes in bowel habits due to increased fiber intake from the BIG MACS Diet.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My colon cancer is in stage 1, 2, or 3.
Select...
I am between 25 and 70 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have had an organ transplant.
Select...
I have HIV, active tuberculosis, malaria, hepatitis B or C, cirrhosis, or inflammatory bowel disease.
Select...
I have had a severe infection in my abdomen before.
Select...
I have had surgery on my stomach, intestines, pancreas, bile duct, gallbladder, or spleen.
Select...
I have significant anemia or a history of bleeding disorders.
Select...
I am 25 years old or younger, or 70 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, time of surgery, postop day 7 and 30
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, time of surgery, postop day 7 and 30
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Bowel emptying patterns
Change in muscle mass
Compliance with the dietary intervention or standard of care- Baseline veggie meter
+8 moreSecondary study objectives
Change in microbiome features- alpha diversity
Change in microbiome features- beta diversity
Changes in body composition- abdominal muscle
+5 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: BIG MACS DietExperimental Treatment1 Intervention
Participants will be instructed to consume the study diet, referred to as the 'BIG MACS Diet' and one protein shake per day for 4 weeks prior to surgery (SOC). Following surgery, participants will continue to follow the BIG MACS Diet for an additional four weeks, with solid food reintroduction after surgery as early as tolerated.
Group II: Standard DietActive Control1 Intervention
Participants receiving only standard of care (SOC) nutrition advice, which is SOC Dietary Instructions, as provided by routine surgical consults and one protein shake per day for 4 weeks prior to surgery (SOC).
Find a Location
Who is running the clinical trial?
University of MinnesotaLead Sponsor
1,439 Previous Clinical Trials
1,621,944 Total Patients Enrolled
Cyrus JahansouzPrincipal InvestigatorUniversity of Minnesota
1 Previous Clinical Trials
40 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You had problems with alcohol, drugs, or opioids, except for smoking, in the last five years.You are in prison.You drink more than one alcoholic drink per day if you're a woman, or more than 20 grams per day if you're a woman, or more than 30 grams per day if you're a man.I have HIV, active tuberculosis, malaria, hepatitis B or C, cirrhosis, or inflammatory bowel disease.I have depression with a CES-D score over 16 and am not considered suitable for surgery by a psychologist.My colon cancer is in stage 1, 2, or 3.I have had an organ transplant.I have had a severe infection in my abdomen before.Your blood test shows that your creatinine level is higher than 1.5 mg/dL.Your blood tests show high levels of bilirubin, alkaline phosphatase, ALT, AST, or INR.I have had surgery on my stomach, intestines, pancreas, bile duct, gallbladder, or spleen.I have significant anemia or a history of bleeding disorders.Your BMI is less than 20 or more than 40.I am 25 years old or younger, or 70 years old or older.My surgery is not for removing colon cancer, preparing for other treatments, or my first treatment.I am between 25 and 70 years old.You have a history of feeling very scared in small, enclosed spaces.You have any type of implant that is not safe for MRI scans, like a pacemaker or metallic hardware.
Research Study Groups:
This trial has the following groups:- Group 1: Standard Diet
- Group 2: BIG MACS Diet
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.